Press releases – Calliditas Therapeutics AB

Read the latest press releases from Calliditas Therapeutics by clicking on a title below.

For press enquiries please contact us.

Sep 8, 2020

First patient in China enrolled in clinical phase 3 study NefIgArd with lead candidate Nefecon

Aug 25, 2020

Calliditas appoints Group General Counsel

Aug 11, 2020

Calliditas Therapeutics to host conference call to provide Business Update and 2020 Q2 report

Jun 22, 2020

CEO Renée Aguiar-Lucander exercises warrants and invests SEK 15.7m (appr. USD 1.7m) in Calliditas

Apr 27, 2020

Calliditas provides a corporate business update in the context of the Covid-19 pandemic

Apr 1, 2020

Calliditas strengthens its US Commercial Organization

Jan 22, 2020

Positive opinion received from EMA Paediatric Committee on the Paediatric Investigation Plan for Nefecon for the treatment of IgAN